Skip to main content
Premium Trial:

Request an Annual Quote

David Smith, Vicky Gwosdz, Mirus, Invitrogen

Premium

People in the News

Galapagos said this week that it has named David Smith as its CFO effective Feb. 1, 2006.

Upon the arrival of Smith, the company said Vicky Gwosdz, currently head of finance, will continue as controller.

Smith comes to Galapagos from AstraZeneca, where he was marketing CFO, as well as a board member of AstraZeneca Dutch Holdings Group.

 

Products & Services

Mirus has recently introduced the Label It mRNA labeling kit.

According to the company, the kit can be used for the rapid and sensitive non-enzymatic labeling of miRNAs for microarray analysis. Each kit includes the miRNA Cy3 and Cy5 reagents, as well as additional buffers and reagents required for labeling reactions. This kit also contains a 1x hybridization solution. Reagents required for sample preparation and sample purification are not included, Mirus noted.


Invitrogen said this week that it has launched the Stealth RNAi human kinase collection.

The company said the collection contains 636 human kinase targets with two individual non-overlapping Stealth RNAi duplexes per target.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.